These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 31823505

  • 1. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
    Liu Y, Zhang B, Lei Y, Xia L, Lu J, Shen H.
    Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
    [Abstract] [Full Text] [Related]

  • 2. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
    Zhao L, Yao L, Yuan L, Xia L, Shen H, Lu J.
    Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
    [Abstract] [Full Text] [Related]

  • 3. [Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome].
    Yang Y, Qi X, Ding M, Wang W, Guo H, Gao L.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct 18; 56(5):845-852. PubMed ID: 39397464
    [Abstract] [Full Text] [Related]

  • 4. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y, Xian Z, Fu D, Liu S, Yao Y, Jin Y, Gao C, Shen L, Shi G, He J.
    Front Immunol; 2021 Oct 18; 12():673658. PubMed ID: 34012457
    [Abstract] [Full Text] [Related]

  • 5. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
    Zhang R, Sun T, Song L, Zuo D, Xiao W.
    Cytokine; 2014 Oct 18; 69(2):289-93. PubMed ID: 24981072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z.
    Int Immunopharmacol; 2020 Nov 18; 88():106878. PubMed ID: 32791244
    [Abstract] [Full Text] [Related]

  • 9. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
    Han M, Li Y, Liu S, Jiang S, Yuan L, Xia L, Shen H, Lu J.
    J Interferon Cytokine Res; 2018 Oct 18; 38(10):452-456. PubMed ID: 30256702
    [Abstract] [Full Text] [Related]

  • 10. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren's syndrome.
    Liuqing W, Liping X, Hui S, Jing L.
    J Investig Med; 2017 Mar 18; 65(3):717-721. PubMed ID: 28057714
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC, Chou PL, Cheng CW, Chang YS, Chi WM, Tsai KL, Chen WJ, Kung TS, Tai CC, Lee KW, Chen YC, Lin CY.
    J Proteomics; 2016 Jun 01; 141():1-11. PubMed ID: 27072115
    [Abstract] [Full Text] [Related]

  • 12. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F, Chen J, Zheng J, Chen Y, Huang R, Yin J, Gao X, Lin Q, Huang C, Gao Y, Yu X, Liu Z.
    Int J Rheum Dis; 2016 Jul 01; 19(7):715-20. PubMed ID: 25941062
    [Abstract] [Full Text] [Related]

  • 13. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
    Sudzius G, Mieliauskaite D, Siaurys A, Viliene R, Butrimiene I, Characiejus D, Dumalakiene I.
    Rheumatol Int; 2014 Feb 01; 34(2):235-41. PubMed ID: 24166212
    [Abstract] [Full Text] [Related]

  • 14. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
    Gan Y, Zhao X, He J, Liu X, Li Y, Sun X, Li Z.
    J Immunol Res; 2017 Feb 01; 2017():4768408. PubMed ID: 28210632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E, Yavuz S, Direskeneli H.
    Br J Ophthalmol; 2004 Mar 01; 88(3):384-7. PubMed ID: 14977774
    [Abstract] [Full Text] [Related]

  • 17. Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury.
    Jin Y, Li J, Chen J, Shao M, Zhang R, Liang Y, Zhang X, Zhang X, Zhang Q, Li F, Cheng Y, Sun X, He J, Li Z.
    J Immunol Res; 2019 Mar 01; 2019():3642937. PubMed ID: 31205955
    [Abstract] [Full Text] [Related]

  • 18. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY, Locke J, Lendrem D, Bowman S, Hargreaves B, Macrae V, UK primary Sjögren’s syndrome registry, Tarn JR, Ng WF.
    Rheumatol Int; 2020 Apr 01; 40(4):541-548. PubMed ID: 32047959
    [Abstract] [Full Text] [Related]

  • 19. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
    Hernández-Molina G, Bermúdez-Bermejo P.
    Int J Rheum Dis; 2017 Jan 01; 20(1):84-89. PubMed ID: 26807556
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP, Tron F, Le Loët X, Vittecoq O.
    Clin Exp Immunol; 2007 May 01; 148(2):281-7. PubMed ID: 17286756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.